INCY241220P55000
- 0.16
- 0.000.00%
Incyte Newsroom
Incyte Is Maintained at Sector Perform by RBC Capital
BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $86
Incyte Analyst Ratings
Stifel Nicolaus Sticks to Its Hold Rating for Incyte (INCY)
TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $80
A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $52 to $86
TD Cowen Remains a Buy on Incyte (INCY)
Incyte Faces Pipeline Setbacks and Growth Challenges, Justifying Sell Rating
Incyte's Strategic Growth Potential and Rich Pipeline Underpin Buy Rating at $86 Target
RBC Cuts Price Target on Incyte to $74 From $80, Keeps Sector Perform Rating
Incyte's Trials and Challenges: Hold Recommendation Amid Clinical and Financial Uncertainties
Incyte Is Maintained at Sector Perform by RBC Capital
Incyte Analyst Ratings
RBC Capital Sticks to Its Hold Rating for Incyte (INCY)
A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $80 to $97
Goldman Sachs Maintains Neutral on Incyte, Raises Price Target to $70
Incyte Is Maintained at Neutral by JP Morgan
Incyte Price Target Raised to $52.00/Share From $48.00 by BMO Capital
A Quick Look at Today's Ratings for Incyte(INCY.US), With a Forecast Between $48 to $97
Argus Adjusts Price Target on Incyte to $80 From $75